250 related articles for article (PubMed ID: 25099257)
1. Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies.
Bu WJ; Song L; Zhao DY; Guo B; Liu J
Br J Clin Pharmacol; 2014 Aug; 78(2):301-9. PubMed ID: 25099257
[TBL] [Abstract][Full Text] [Related]
2. Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis.
Yin S; Bai H; Jing D
Diagn Pathol; 2014 May; 9():91. PubMed ID: 24885616
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies.
Yu F; Guo Y; Wang H; Feng J; Jin Z; Chen Q; Liu Y; He J
BMC Cancer; 2016 Aug; 16():642. PubMed ID: 27535548
[TBL] [Abstract][Full Text] [Related]
4. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
[TBL] [Abstract][Full Text] [Related]
5. Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.
Karlstad O; Starup-Linde J; Vestergaard P; Hjellvik V; Bazelier MT; Schmidt MK; Andersen M; Auvinen A; Haukka J; Furu K; de Vries F; De Bruin ML
Curr Drug Saf; 2013 Nov; 8(5):333-48. PubMed ID: 24215311
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinediones and risk of colorectal cancer in patients with diabetes mellitus: A meta-analysis.
Liu Y; Jin PP; Sun XC; Hu TT
Saudi J Gastroenterol; 2018; 24(2):75-81. PubMed ID: 29637913
[TBL] [Abstract][Full Text] [Related]
7. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of insulin in type 2 diabetes: meta-analysis of randomised controlled trials.
Erpeldinger S; Rehman MB; Berkhout C; Pigache C; Zerbib Y; Regnault F; Guérin E; Supper I; Cornu C; Kassaï B; Gueyffier F; Boussageon R
BMC Endocr Disord; 2016 Jul; 16(1):39. PubMed ID: 27391319
[TBL] [Abstract][Full Text] [Related]
9. Insulin therapy contributes to the increased risk of colorectal cancer in diabetes patients: a meta-analysis.
Wang L; Cai S; Teng Z; Zhao X; Chen X; Bai X
Diagn Pathol; 2013 Oct; 8():180. PubMed ID: 24175949
[TBL] [Abstract][Full Text] [Related]
10. Association between insulin therapy and risk of liver cancer among diabetics: a meta-analysis of epidemiological studies.
Liu XL; Wu H; Zhao LG; Xu HL; Zhang W; Xiang YB
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):1-8. PubMed ID: 29064852
[TBL] [Abstract][Full Text] [Related]
11. CARING (CAncer Risk and INsulin analoGues): the association of diabetes mellitus and cancer risk with focus on possible determinants - a systematic review and a meta-analysis.
Starup-Linde J; Karlstad O; Eriksen SA; Vestergaard P; Bronsveld HK; de Vries F; Andersen M; Auvinen A; Haukka J; Hjellvik V; Bazelier MT; Boer Ad; Furu K; De Bruin ML
Curr Drug Saf; 2013 Nov; 8(5):296-332. PubMed ID: 24215312
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis of insulin therapy and risk of cancer.
Janghorbani M; Dehghani M; Salehi-Marzijarani M
Horm Cancer; 2012 Aug; 3(4):137-46. PubMed ID: 22528451
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
[TBL] [Abstract][Full Text] [Related]
14. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
15. Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis.
He XK; Su TT; Si JM; Sun LM
Medicine (Baltimore); 2016 Feb; 95(7):e2749. PubMed ID: 26886616
[TBL] [Abstract][Full Text] [Related]
16. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
[TBL] [Abstract][Full Text] [Related]
17. Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis.
Meng F; Song L; Wang W
J Diabetes Res; 2017; 2017():5063239. PubMed ID: 28271076
[No Abstract] [Full Text] [Related]
18. Insulin therapy and risk of prostate cancer: a systematic review and meta-analysis of observational studies.
Chen YB; Chen Q; Wang Z; Zhou J
PLoS One; 2013; 8(11):e81594. PubMed ID: 24282613
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Nie SP; Chen H; Zhuang MQ; Lu M
Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538
[TBL] [Abstract][Full Text] [Related]
20. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis.
Wang Q; Shi M
Anticancer Drugs; 2022 Feb; 33(2):191-199. PubMed ID: 34620743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
